News
CADTH is seeking nominations for its advisory and expert committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the Canadian health care system is the best it can be...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Iluvien
Generic name
fluocinolone acetonide intravitreal implant
Manufacturer
Knight Therapeutics Inc.
Indication(s)
diabetic macular edema
Project Number
SR0608-000
Call for patient input
2019-03-06
Patient input deadline
2019-04-25
Submit patient input
Submit...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Translarna
Generic name
ataluren
Manufacturer
PTC Therapeutics Canada ULC
Indication(s)
Dystrophinopathy
Project Number
SR0607-000
Call for patient input
2019-03-05
Patient input deadline
2019-04-24
Submit patient input
Submit
Register as Clinical Expert
Regis...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Revestive
Generic name
teduglutide
Manufacturer
Shire Pharmaceuticals Ireland Limited
Indication(s)
Short Bowel Syndrome (SBS), pediatrics
Project Number
SR0606-000
Call for patient input
2019-03-04
Patient input deadline
2019-04-23
Submit patient input
Submit...
